NTUS insider filings
NATUS MEDICAL INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-07-21. Screen NTUS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for NTUS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — NATUS MEDICAL INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-07-21 | 4 | MOORE BRYANT M — Director | Disposition to issuer (D): 10,114 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | Guerin Eric — Director | Disposition to issuer (D): 10,114 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | SCHROEDER ALICE D. — Director | Disposition to issuer (D): 22,406 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | Heine Lisa Wipperman — Director | Disposition to issuer (D): 26,287 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | Davies Benjamin Drew — Executive VP and CFO | Grant/award (A): 106,034 @ $0 · Disposition to issuer (D): 181,846 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | Noll Austin Francis III — Executive VP and CCO | Grant/award (A): 61,966 @ $0 · Disposition to issuer (D): 200,509 @ $33.50 · Disposition to issuer (D): 72,534 (derivative) @ $12.82 | EDGAR |
| 2022-07-21 | 4 | Sullivan Thomas Joseph — President and CEO, Director | Grant/award (A): 648,554 @ $0 · Disposition to issuer (D): 720,903 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | Daskal Ilan — Director | Disposition to issuer (D): 18,937 @ $33.50 | EDGAR |
| 2022-07-21 | 4 | CHUNG DONG CHUNE CHRISTOPHER — Chief Medical Officer | Grant/award (A): 35,056 @ $0 · Disposition to issuer (D): 83,374 @ $33.50 · Disposition to issuer (D): 35,360 (derivative) @ $12.82 | EDGAR |
| 2022-07-21 | 4 | LEVINE JOSHUA — Director | Disposition to issuer (D): 37,387 @ $33.50 | EDGAR |
| 2022-06-17 | 4 | MOORE BRYANT M — Director | Grant/award (A): 4,315 @ $0 | EDGAR |
| 2022-06-17 | 4 | Guerin Eric — Director | Grant/award (A): 4,315 @ $0 | EDGAR |
| 2022-06-17 | 4 | SCHROEDER ALICE D. — Director | Grant/award (A): 5,075 @ $0 | EDGAR |
| 2022-06-17 | 4 | Heine Lisa Wipperman — Director | Grant/award (A): 5,075 @ $0 | EDGAR |
| 2022-06-17 | 4 | Daskal Ilan — Director | Grant/award (A): 5,075 @ $0 | EDGAR |
| 2022-06-17 | 4 | LEVINE JOSHUA — Director | Grant/award (A): 5,075 @ $0 | EDGAR |
| 2022-01-06 | 4 | Davies Benjamin Drew — Executive VP and CFO | Tax withholding (F): 1,251 @ $24.02 | EDGAR |
| 2022-01-06 | 4 | Noll Austin Francis III — Executive VP and CCO | Tax withholding (F): 3,710 @ $24.02 | EDGAR |
| 2022-01-06 | 4 | CHUNG DONG CHUNE CHRISTOPHER — Chief Medical Officer | Tax withholding (F): 2,796 @ $24.02 | EDGAR |
| 2022-01-04 | 4 | Davies Benjamin Drew — Executive VP and CFO | Grant/award (A): 5,252 @ $23.73 · Tax withholding (F): 2,486 @ $23.73 · Tax withholding (F): 3,621 @ $23.73 · Grant/award (A): 19,334 @ $24 | EDGAR |
| 2022-01-04 | 4 | Noll Austin Francis III — Executive VP and CCO | Grant/award (A): 3,676 @ $23.73 · Tax withholding (F): 1,602 @ $23.73 · Tax withholding (F): 4,904 @ $23.73 · Grant/award (A): 25,625 @ $24 | EDGAR |
| 2022-01-04 | 4 | Sullivan Thomas Joseph — President and CEO, Director | Grant/award (A): 52,084 @ $24 | EDGAR |
| 2022-01-04 | 4 | CHUNG DONG CHUNE CHRISTOPHER — Chief Medical Officer | Grant/award (A): 2,363 @ $23.73 · Tax withholding (F): 1,213 @ $23.73 · Tax withholding (F): 4,046 @ $23.73 · Grant/award (A): 14,084 @ $24 | EDGAR |
| 2021-12-13 | 4 | CHUNG DONG CHUNE CHRISTOPHER — Chief Medical Officer | Option exercise (M): 11,787 @ $20.68 · Sale (S): 11,787 @ $23.08 · Option exercise (M): 11,787 (derivative) @ $20.68 | EDGAR |
| 2021-10-05 | 4 | Davies Benjamin Drew — Executive VP and CFO | Tax withholding (F): 2,664 @ $25.86 | EDGAR |
| 2021-08-20 | 4 | MOORE BRYANT M — Director | Grant/award (A): 5,799 @ $25.87 | EDGAR |
| 2021-08-20 | 4 | Guerin Eric — Director | Grant/award (A): 5,799 @ $25.87 | EDGAR |
| 2021-06-21 | 4 | SCHROEDER ALICE D. — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-21 | 4 | Heine Lisa Wipperman — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-21 | 4 | Sullivan Thomas Joseph — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-21 | 4 | Daskal Ilan — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-21 | 4 | PAUL BARBARA R — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-21 | 4 | LEVINE JOSHUA — Director | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-15 | 4 | SCHROEDER ALICE D. — Director | Sale (S): 2,934 @ $27.49 | EDGAR |
| 2021-06-15 | 4 | Daskal Ilan — Director | Sale (S): 2,500 @ $27.46 | EDGAR |
| 2021-06-01 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Sale (S): 10,467 @ $27.10 · Sale (S): 808 @ $26.90 · Sale (S): 12,500 @ $27.55 | EDGAR |
| 2021-05-26 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Sale (S): 20,000 @ $27.11 · Sale (S): 9,435 @ $27.41 | EDGAR |
| 2021-05-20 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Sale (S): 2,904 @ $26.90 · Sale (S): 6,367 @ $26.54 · Sale (S): 9,290 @ $27 | EDGAR |
| 2021-05-14 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Sale (S): 10,108 @ $27.47 · Sale (S): 27,721 @ $27.96 · Sale (S): 21,927 @ $28.31 | EDGAR |
| 2021-05-04 | 4 | Noll Austin Francis III — Executive VP and CCO | Grant/award (A): 489 @ $21.72 | EDGAR |
| 2021-05-04 | 4 | Kennedy Jonathan — President and CEO, Director | Grant/award (A): 489 @ $21.72 | EDGAR |
| 2021-04-16 | 4/A | Kennedy Jonathan — President and CEO, Director | Grant/award (A): 200,146 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Davies Benjamin Drew — Executive VP and CFO | Other (J): 23,845 @ $20.04 · Tax withholding (F): 3,670 @ $20.04 · Grant/award (A): 20,622 @ $20.61 | EDGAR |
| 2021-01-05 | 4 | Noll Austin Francis III — Executive VP and CCO | Tax withholding (F): 6,704 @ $20.04 · Grant/award (A): 33,965 @ $20.61 | EDGAR |
| 2021-01-05 | 4 | Kennedy Jonathan — President and CEO, Director | Other (J): 22,695 @ $20.04 · Tax withholding (F): 14,985 @ $20.04 · Grant/award (A): 66,716 @ $20.61 · Grant/award (A): 66,716 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Tax withholding (F): 5,263 @ $20.04 · Grant/award (A): 21,835 @ $20.61 | EDGAR |
| 2020-11-17 | 4 | Noll Austin Francis III — Executive VP and CCO | Grant/award (A): 72,534 (derivative) @ $0 | EDGAR |
| 2020-11-17 | 4 | CHUNG DONG CHUNE CHRISTOPHER — VP of Medical Affairs | Grant/award (A): 47,147 (derivative) @ $0 | EDGAR |
| 2020-11-03 | 4 | Noll Austin Francis III — Executive VP and CCO | Grant/award (A): 686 @ $15.48 | EDGAR |
| 2020-11-03 | 4 | Kennedy Jonathan — President and CEO, Director | Grant/award (A): 686 @ $15.48 | EDGAR |
Recent 8-K events — NATUS MEDICAL INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-07-21 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-04-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-01-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-12-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NTUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs